Overview

The Application of Ursodeoxycholic Acid for the Prevention of Novel Coronavirus Infections

Status:
Not yet recruiting
Trial end date:
2023-02-18
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of ursodeoxycholic acid in blocking the transmission of infectious novel coronaviruses in a population of medical workers
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital
Treatments:
Ursodeoxycholic Acid